Weinstein Cardiovascular Development and Regeneration Conference

韦恩斯坦心血管发育与再生会议

• 批准号: 10683505
• 负责人: DEBORAH YELON
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-15 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10683505
• 关键词: Adult; Affect; American Heart Association; Award; California; Cardiac; Cardiovascular Diseases; Cardiovascular system; Categories; Childhood; Clinical; Collaborations; Committee Members; Communities; Comprehension; Congenital Abnormality; Data; Development; Developmental Biology; Disabled Persons; Embryology; Engineering; Environment; Etiology; Europe; Event; Faculty; Fees; Financial Support; Funding; Gene Expression; Goals; Growth; Health; Human Genetics; Individual; Infant Mortality; Institution; Live Birth; Medical; Mentors; Mission; Molecular; Myocardial dysfunction; National Heart, Lung, and Blood Institute; Natural regeneration; Oral; Parents; Pathology; Patients; Postdoctoral Fellow; Publishing; Regenerative Medicine; Regulation; Reporting; Request for Applications; Request for Proposals; Research; Research Personnel; Scientist; Seasons; Series; Societies; Structural Congenital Anomalies; Talents; Therapeutic; Tissue Engineering; Training; Transcriptional Regulation; Travel; Underrepresented Populations; Universities; Woman; Work; cardiogenesis; career; collaborative environment; congenital heart disorder; cost; early-career faculty; gene function; graduate student; improved; innovation; meetings; next generation; novel; prevent; secondary outcome; stillbirth; symposium; symptom treatment; targeted treatment

PROJECT SUMMARY This proposal requests support for the 2023 Weinstein Cardiovascular Development and Regeneration Conference, which will be held in San Diego, California. The Weinstein Cardiovascular Development and Regeneration Conference was founded to create an open forum for investigators studying the etiology, pathology, and eventual treatment of congenital heart diseases (CHDs). This tradition initiated with a series of annual meetings that brought together investigators who were funded by three separate NIH RFAs on Cardiac Development; these RFAs, the first of which was issued in 1984, were sponsored by Dr. Constance Weinstein and her colleagues at the NHLBI. Since its origins, this conference has been the premier opportunity for researchers in the field of cardiovascular developmental biology to meet and share their data and ideas. During the 3-day meeting, basic scientists, clinicians, engineers, and geneticists come together to interact and discuss a multitude of cardiovascular developmental mechanisms and their impact on CHDs, as well as the secondary outcomes that result in adult cardiac dysfunction. This conference is unique for several reasons. First, it is a freestanding meeting that is entirely organized by active researchers within the cardiovascular developmental biology community who are unaffiliated with any society or parent organization. Second, with the exception of the keynote speakers, all oral platform presentations are chosen from abstracts submitted by early career faculty, postdoctoral fellows, and graduate students. This approach insures that only cutting-edge data are shown and avoids repetitive presentations by established investigators selected solely by reputation. Third, this conference is consistently attended by a substantial number of senior investigators in the cardiovascular developmental biology field, even though they are not delivering oral presentations and are required to pay for their own registration and travel expenses. Fourth, the conference community maintains a welcoming and collaborative atmosphere that encourages sharing of innovative and unpublished data. As in prior iterations of this conference, the objectives of the 2023 Weinstein Cardiovascular Development and Regeneration Conference are to promote a collegial environment for dissemination and discussion of innovative and unpublished scientific findings, to encourage interactions and collaborations among colleagues in the field, and to enhance the professional development of a diverse array of early career faculty, postdoctoral fellows, and graduate students by providing a platform for the presentation of their data and an opportunity to network and interact with established cardiovascular developmental biologists. In this application, financial support is requested to subsidize registration fees for trainees in order to encourage robust attendance of early career researchers, to provide financial assistance in the form of travel awards for selected trainees, with a particular focus on supporting attendance of women, underrepresented groups, and individuals with disabilities, and to support general conference costs.

项目摘要 该提案要求支持2023年温斯坦心血管发育和再生 会议，这将是在圣地亚哥举行，加州。温斯坦心血管发展和 再生会议的成立是为了为研究病因的研究人员创造一个开放的论坛， 病理学，并最终治疗先天性心脏病（CHD）。这一传统始于一系列 每年的会议聚集了由三个独立的NIH心脏RFA资助的研究人员， 发展;这些RFA，其中第一个是在1984年发布的，由康斯坦斯·温斯坦博士赞助。 和她在NHLBI的同事们自成立以来，本次会议一直是 心血管发育生物学领域的研究人员会面并分享他们的数据和想法。期间 为期3天的会议，基础科学家，临床医生，工程师和遗传学家聚集在一起互动和讨论 许多心血管发育机制及其对CHD的影响，以及继发性 导致成人心脏功能障碍的结果。这次会议之所以独特，有几个原因。一是 独立的会议，完全由心血管发展领域的活跃研究人员组织， 不隶属于任何社会或上级组织的生物学社区。第二，除了 主讲人，所有口头平台的演讲都是从早期职业生涯提交的摘要中选择的 教师、博士后研究员和研究生。这种方法确保只有尖端数据 显示，并避免重复演示由建立调查人员选择完全由声誉。第三，这 会议始终由心血管领域的大量高级研究人员参加， 发育生物学领域，即使他们不提供口头报告，并要求支付 他们自己的注册和旅行费用。第四，会议社区保持欢迎和 鼓励共享创新和未发布数据的协作氛围。与之前的迭代一样， 2023年温斯坦心血管发育和再生的目标 会议旨在促进传播和讨论创新和 未发表的科学发现，以鼓励该领域同事之间的互动和合作，以及 加强各种早期职业教师，博士后研究员的专业发展， 研究生通过提供一个平台，为他们的数据和网络的机会， 与心血管发育生物学家互动。在这个应用程序中，财政支持是 要求资助学员的注册费，以鼓励大量参加早期职业培训 研究人员，以旅行奖的形式为选定的受训人员提供财政援助， 重点支持妇女、代表性不足的群体和残疾人的入学， 支助大会费用。